Peloton Wealth Strategists’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $957K | Sell |
1,703
-1,130
| -40% | -$725K | 0.39% | 63 |
|
|
2025
Q4 | $1.92M | Sell |
2,833
-40
| -1% | -$27.2K | 0.74% | 51 |
|
|
2025
Q3 | $1.84M | Sell |
2,873
-170
| -6% | -$103K | 0.72% | 53 |
|
|
2025
Q2 | $1.63M | Buy |
3,043
+530
| +21% | +$253K | 0.65% | 56 |
|
|
2025
Q1 | $1.05M | Buy |
2,513
+1,953
| +349% | +$848K | 0.44% | 66 |
|
|
2024
Q4 | $232K | Buy |
+560
| New | +$246K | 0.09% | 89 |
|
|
2021
Q1 | – | Sell |
-8,375
| Closed | -$4.19M | – | 87 |
|
|
2020
Q4 | $4.19M | Sell |
8,375
-1,066
| -11% | -$477K | 2.07% | 20 |
|
|
2020
Q3 | $3.71M | Sell |
9,441
-1,790
| -16% | -$662K | 2.08% | 18 |
|
|
2020
Q2 | $3.71M | Sell |
11,231
-150
| -1% | -$43.4K | 2.34% | 13 |
|
|
2020
Q1 | $2.76M | Sell |
11,381
-2,000
| -15% | -$522K | 2.25% | 13 |
|
|
2019
Q4 | $3.49M | Sell |
13,381
-1,100
| -8% | -$290K | 2.12% | 14 |
|
|
2019
Q3 | $3.94M | Sell |
14,481
-1,250
| -8% | -$348K | 2.52% | 11 |
|
|
2019
Q2 | $4.33M | Sell |
15,731
-60
| -0.4% | -$14.8K | 2.9% | 6 |
|
|
2019
Q1 | $3.53M | Sell |
15,791
-100
| -0.6% | -$20.6K | 2.44% | 13 |
|
|
2018
Q4 | $2.96M | Buy |
15,891
+350
| +2% | +$71.8K | 2.41% | 11 |
|
|
2018
Q3 | $3.88M | Sell |
15,541
-516
| -3% | -$125K | 2.67% | 7 |
|
|
2018
Q2 | $3.5M | Sell |
16,057
-100
| -0.6% | -$20.6K | 2.53% | 9 |
|
|
2018
Q1 | $3.09M | Sell |
16,157
-100
| -0.6% | -$18.5K | 2.33% | 13 |
|
|
2017
Q4 | $2.54M | Sell |
16,257
-150
| -0.9% | -$23.6K | 1.89% | 24 |
|
|
2017
Q3 | $2.55M | Sell |
16,407
-100
| -0.6% | -$15.8K | 1.97% | 21 |
|
|
2017
Q2 | $2.67M | Sell |
16,507
-572
| -3% | -$92.9K | 2.07% | 18 |
|
|
2017
Q1 | $2.64M | Sell |
17,079
-178
| -1% | -$24.5K | 2.17% | 18 |
|
|
2016
Q4 | $2.02M | Hold |
17,257
| – | – | 1.65% | 22 |
|
|
2016
Q3 | $1.95M | Buy |
+17,257
| New | +$1.82M | 1.62% | 26 |
|
|
2016
Q1 | $1.39M | Sell |
17,700
-400
| -2% | -$28.8K | 1.17% | 39 |
|
|
2015
Q4 | $1.32M | Hold |
18,100
| – | – | 1.14% | 39 |
|
|
2015
Q3 | $1.34M | Sell |
18,100
-700
| -4% | -$50.1K | 1.17% | 42 |
|
|
2015
Q2 | $1.21M | Sell |
18,800
-200
| -1% | -$13.8K | 0.96% | 53 |
|
|
2015
Q1 | $1.47M | Hold |
19,000
| – | – | 1.14% | 43 |
|
|
2014
Q4 | $1.41M | Hold |
19,000
| – | – | 1.07% | 45 |
|
|
2014
Q3 | $1.12M | Sell |
19,000
-16,256
| -46% | -$1.03M | 0.88% | 50 |
|
|
2014
Q2 | $1.64M | Buy |
35,256
+16,156
| +85% | +$1.03M | 1.44% | 28 |
|
|
2014
Q1 | $1.16M | Sell |
19,100
-600
| -3% | -$35.7K | 0.95% | 46 |
|
|
2013
Q4 | $1.05M | Sell |
19,700
-3,400
| -15% | -$179K | 0.85% | 47 |
|
|
2013
Q3 | $1.15M | Buy |
23,100
+2,200
| +11% | +$106K | 0.97% | 46 |
|
|
2013
Q2 | $937K | Buy |
+20,900
| New | +$913K | 0.84% | 47 |
|
Other funds holding IDXX
VCM
VPM
Peloton Wealth Strategists's IDXX Position: Q1 2026 in Review
Peloton Wealth Strategists reduced its Idexx Laboratories (IDXX) stake by 40% in Q1 2026, selling an estimated $725K and leaving 1,703 shares worth $957K. The position accounts for 0.39% of the portfolio, ranked #63.
Peloton Wealth Strategists first reported a position in IDXX in Q2 2013 and has held it in 36 quarters since. The position peaked at $4.33M in Q2 2019. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Peloton Wealth Strategists held 1,703 shares of Idexx Laboratories worth $957K as of Q1 2026.
- Peloton Wealth Strategists sold 1,130 Idexx Laboratories shares in Q1 2026, an estimated $725K.
- Idexx Laboratories made up 0.39% of Peloton Wealth Strategists's portfolio in Q1 2026, its #63 holding.
- Peloton Wealth Strategists first reported a position in Idexx Laboratories in Q2 2013 and has held it in 36 quarters since.
- Peloton Wealth Strategists's Idexx Laboratories position peaked at $4.33M in Q2 2019.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Peloton Wealth Strategists's 13F filing for Q1 2026, filed 14 May 2026.